Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09BDH
|
|||
Former ID |
DIB008887
|
|||
Drug Name |
Rabeximod
|
|||
Synonyms |
Rob-803; B-220 analog (RA), OxyPharma; B-220 analog (rheumatoid arthritis), OxyPharma
Click to Show/Hide
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
OxyPharma AB
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H24ClN5O
|
|||
Canonical SMILES |
CC1=CC2=C(C=C1C)N=C3C(=N2)C4=C(N3CC(=O)NCCN(C)C)C=CC(=C4)Cl
|
|||
InChI |
1S/C22H24ClN5O/c1-13-9-17-18(10-14(13)2)26-22-21(25-17)16-11-15(23)5-6-19(16)28(22)12-20(29)24-7-8-27(3)4/h5-6,9-11H,7-8,12H2,1-4H3,(H,24,29)
|
|||
InChIKey |
PDNNUMNEXITLCZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 872178-65-9
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00525213) Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.